Stereotaxic neurosurgery in laboratory rodent: Handbook on best practices

Stereotaxic Neurosurgery in Laboratory Rodent: Handbook on Best Practices

Volumn , Issue , 2014, Pages 1-181

  Ferry, Barbara ^a   Gervasoni, Damien ^a   Vogt, Catherine ^a  

^a UNIVERSITÉ LYON 1   (France)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 84899015614     PISSN: None     EISSN: None     Source Type: Book    
DOI: 10.1007/978-2-8178-0472-9     Document Type: Book

References (246)

1. Button KS, Ioannidis JP, Mokrysz C, Nosek BA, Flint J, Robinson ES, Munafo MR (2013) Power failure: why small sample size undermines the reliability of neuroscience. Nat Rev Neurosci 14:365-376.
2. Canadian Council on Animal Care (2013a) Guide to the care and use of experimental animals: Chapter XIX (laboratory mice). http://www.ccac.ca/Documents/Standards/Guidelines/Vol2/ mice.pdf. Accessed 10 Sept 2013.
3. Canadian Council on Animal Care (2013b) Guide to the care and use of experimental animals: Chapter XXI (laboratory rats). http://www.ccac.ca/Documents/Standards/Guidelines/Vol2/ rats.pdf. Accessed 10 Sept 2013.
4. Committee for the Update of the Guide for the Care and Use of Laboratory Animals, Institute for Laboratory Animal Research, Division on Earth and Life Studies, National Research Council (2011) Guide for the care and use of laboratory animals, 8th edn. National Academies Press. ISBN 0309154006. http://www.nap.edu/catalog.php?record_id=12910. Accessed 10 Sept 2013.
5. Committee on Guidelines for the Use of Animals in Neuroscience and Behavioral Research, National Research Council, Institute for Laboratory Animal Research, Division on Earth and Life Studies (2003) Guidelines for the care and use of mammals in neuroscience and behavioral research, National Academies Press. ISBN 0309089034. http://www.nap.edu/catalog. php?record_id=10732. Accessed 10 Sept 2013.
6. Committee on Recognition and Alleviation of Pain in Laboratory Animals, Institute for Laboratory Animal Research, Division on Earth and Life Studies, National Research Council (2009) Recognition and alleviation of pain in laboratory animals. National Academies Press. ISBN 9780309128346. http://www.nap.edu/catalog.php?record_id=12526. Accessed 10 Sept 2013.
7. Dubner R (1987) Research on pain mechanisms in animals. J Am Vet Med Assoc 191:1273-1276.
8. Fitts DA (2010a) The variable-criteria sequential stopping rule: generality to unequal sample sizes, unequal variances, or to large ANOVAs. Behav Res Methods 42:918-929.
9. Fitts DA (2010b) Improved stopping rules for the design of effi cient small-sample experiments in biomedical and biobehavioral research. Behav Res Methods 42:3-22.
10. Guillen J (2012) FELASA guidelines and recommendations. J Am Assoc Lab Anim Sci 51:311-321.
11. Institute of Medicine, Committee on Co-Administration of Service and Research Programs of the National Institutes of Health, the Alcohol, Drug Abuse, and Mental Health Administration, and Related Agencies (1991) Research and service programs in the PHS: challenges in organization, National Academies Press, ISBN 9780309045810. http://download.nap.edu/cart/download. cgi?&record_id=1871. Accessed 10 Sept 2013.
12. Kirik D, Rosenblad C, Bjorklund A (1998) Characterization of behavioral and neurodegenerative changes following partial lesions of the nigrostriatal dopamine system induced by intrastriatal 6-hydroxydopamine in the rat. Exp Neurol 152:259-277.
13. Nicklas W, Baneux P, Boot R, Decelle T, Deeny AA, Fumanelli M, Illgen-Wilcke B (2002) Recommendations for the health monitoring of rodent and rabbit colonies in breeding and experimental units. Lab Anim 36:20-42.
14. Offi ce of Laboratory Animal Welfare, National Institute of Health (2002) Public health service policy on humane care and use of laboratory animals. http://grants.nih.gov/grants/olaw/references/ phspol.htm. Accessed 10 Sept 2013.
15. Rehbinder C, Baneux P, Forbes D, van Herck H, Nicklas W, Rugaya Z, Winkler G (1996) FELASA recommendations for the health monitoring of mouse, rat, hamster, gerbil, guinea pig and rabbit experimental units. Report of the Federation of European Laboratory Animal Science Associations (FELASA) Working Group on Animal Health accepted by the FELASA Board of Management, November 1995. Lab Anim 30:193-208.
16. Russell WMS, Burch RL (1959) The principles of humane experimental technique. Methuen, London.
17. Schwarting RK, Huston JP (1996a) Unilateral 6-hydroxydopamine lesions of meso-striatal dopamine neurons and their physiological sequelae. Prog Neurobiol 49:215-266.
18. Schwarting RK, Huston JP (1996b) The unilateral 6-hydroxydopamine lesion model in behavioral brain research. Analysis of functional defi cits, recovery and treatments. Prog Neurobiol 50:275-331.
19. Ungerstedt U (1971) Postsynaptic supersensitivity after 6-hydroxy-dopamine induced degeneration of the nigro-striatal dopamine system. Acta Physiol Scand Suppl 367:69-93.
20. Voipio HM, Baneux P, Gomez de Segura IA, Hau J, Wolfensohn S (2008) Guidelines for the veterinary care of laboratory animals: report of the FELASA/ECLAM/ESLAV Joint Working Group on Veterinary Care. Lab Anim 42:1-11.
21. Dono R (2003) Fibroblast growth factors as regulators of central nervous system development and function. Am J Physiol Regul Integr Comp Physiol 284(4):867-881.
22. Duester G (2008) Retinoic acid synthesis and signaling during early organogenesis. Cell 134(6):921-931.
23. Jessell TM, Kandel ER, Schwartz JH (2000) Principles of neural science, 4th edn. McGraw-Hill, New York.
24. Mtui E, Gruener G (2006) Clinical neuroanatomy and neuroscience. Saunders, Philadelphia.
25. Paxinos G, Watson C (1998) The rat brain in stereotaxic coordinates, 4th edn. Academic, San Diego.
26. Saladin K (2012) Anatomy & physiology: the unity of form and function, 6th edn. McGraw-Hill, New York.
27. Angevine J, Cotman C (1981) The principles of neuroanatomy. Oxford University Press, New York.
28. Bloom F (1985) Brain, mind, and behavior. WH Freeman and Co. Press, New York.
29. Butler A (1996) Comparative vertebrate neuroanatomy. Wiley-Liss, New York.
30. Chiassen R, Radke W (1993) Laboratory anatomy of the vertebrates. WCB Publishers, Dubuque.
31. Cohen M, Strumwasser F (1985) Comparative neurobiology. Wiley, New York.
32. Eccles J (1973) The understanding of the brain. McGraw-Hill, New York.
33. Karger S (1973) Central nervous system of vertebrates, vol 3, Part II. Arnold- Backlin-Strasse, New York.
34. Kenneth S (2012) Anatomy and physiology: the unity of form and functions. McGraw Hill, New York.
35. Kesner R, Olton D, Kesner R, Olton D (1990) Neurobiology of comparative cognition. Lawrence Erlbaum Associates, Hillsdale.
36. Kuhlenbeck H (1973) Central nervous system of vertebrates, vol 3, Part II. Arnold-Backlin-Strasse, New York.
37. Nichols J, Martin A, Wallace B (1992) From neuron to brain, 3rd edn. Sinauer Associates, Sunderland.
38. Peters A, Palay S, Webster H (1991) The fi ne structure of the nervous system, 3rd edn. Oxford University Press, New York.
39. Prosser C, Prosser C (1991) Neural and integrative animal physiology, 4th edn. Wiley-Liss, New York.
40. Rice D, Barone S Jr (2000) Critical periods for the developing nervous system: evidence from humans and animal models. Environ Health Perspect 108(3): 511-533.
41. Verley R (1977) Comparative development of the mammalian nervous system. Revue d'électroencéphalographie et de Neurophysiologie Clinique 7(3):245-254.
42. Barnes NM, Sharp T (1999) A review of central 5-HT receptors and their function. Neuropharmacology 38(8):1083-1152.
43. Berger P, Farrel K, Sharp F, Skolnick P (1994) Drugs acting at the strychnine-insensitive glycine receptor do not induce HSP-70 protein in the cingulate cortex. Neurosci Lett 168(1-2): 147-150.
44. Berger M, Gray JA, Roth BL (2009) The expanded biology of serotonin. Annu Rev Med 60:355-366.
45. Berridge CW, Stratford TL, Foote SL, Kelley AE (1997) Distribution of dopamine-betahydroxylase- like immunoreactive fi bers within the shell subregion of the nucleus accumbens. Synapse 27:230-241.
46. Binns KE, Turner JP, Salt TE (2003) Kainate receptor (GluR5) - mediated disinhibition of responses in rat ventrobasal thalamus allows a novel sensory processing mechanism. J Physiol 551(Pt 2):525-537.
47. Bjorklund A, Hokfelt T, Kuhar MJ (2005) The handbook of chemical neuroanatomy. Elsevier, Amsterdam.
48. Bockaert J, Claeysen S, Compan V, Dumuis A (2011) 5-HT(4) receptors, a place in the sun: act two. Curr Opin Pharmacol 11(1):87-93.
49. Bolea S, Avignone E, Berretta N, Sanchez-Andres JV, Cherubini E (1999) Glutamate controls the induction of GABA-mediated giant depolarizing potentials through AMPA receptors in neonatal rat hippocampal slices. J Neurophysiol 81(5):2095-2102.
50. Bon C, Galvan M (1996) Electrophysiological actions of GABAB agonists and antagonists in rat dorso-lateral septal neurones in vitro. Br J Pharmacol 118(4):961-967.
51. Borne RF (1994) Serotonin: the neurotransmitter for the'90s. Drug Topics 10:108-120.
52. Chebib M, Hinton T, Schmid KL et al (2009) Novel, potent, and selective GABA C antagonists inhibit myopia development and facilitate learning and memory. J Pharmacol Exp Ther 328(2): 448-457.
53. Chen ZJ, Minneman KP (2005) Recent progress in alpha 1 -adrenergic receptor research. Acta Pharmacol Sin 26(11):1281-1287.
54. Chu HY, Yang Z, Zhao B, Jin GZ, Hu GY, Zhen X (2010) Activation of phosphatidyl-inositollinked D1-like receptors increases spontaneous glutamate release in rat somatosensory cortical neurons in vitro. Brain Res 1343:20-27.
55. Cooper JR, Bloom FL, Roth RH (2003) The biochemical basis of neuropharmacology, 8th edn. Oxford Academy Press, Oxford.
56. Costall B, Naylor RJ (1991) Pharmacological properties and functions of central 5-HT3 receptors. Therapie 46(6):437-444.
57. Cowen PJ (1991) Serotonin receptor subtypes: implications for psychopharmacology. Br J Psychiat 12:7-14.
58. Crunelle CL, Miller ML, Booij J, van den Brink W (2010) The nicotinic acetylcholine receptor partial agonist varenicline and the treatment of drug dependence: a review. Eur Neuropsychopharmacol 20(2):69-79.
59. Cuche H (1981) Séminaire de psychiatrie biologique, Hôpital Sainte-Anne, tome 1. Edition Medicales Fournier Freres, Gennevilliers, pp 107-125.
60. D'Aoust JP, Tiberi M (2010) Role of the extracellular amino terminus and fi rst membrane spanning helix of dopamine D1 and D5 receptors in shaping ligand selectivity and effi cacy. Cell Signal 22(1):106-116.
61. Dahlstrom A, Fuxe K (1964) Localization of monoamines in the lower brain stem. Experientia 20:398-399.
62. Danysz W, Parsons CG (1998) Glycine and N -methyl- d -aspartate receptors: physiological signifi - cance and possible therapeutic applications. Pharmacol Rev 50(4):597-664.
63. Dawson LA (2011) The central role of 5-HT6 receptors in modulating brain neurochemistry. Int Rev Neurobiol 96:1-26.
64. De Biasi M, Dani JA (2011) Reward, addiction, withdrawal to nicotine. Annu Rev Neurosci 34:105-130.
65. El-Ghundi M, O'Dowd BF, George SR (2007) Insights into the role of dopamine receptor systems in learning and memory. Rev Neurosci 18(1):37-66.
66. Epelbaum J (1995) Neuropeptides et neuromédiateurs, 2eth edn. Editions Inserm/Sandoz, Paris.
67. Erlander MG, Lovenberg TW, Baron BM et al (1993) Two members of a distinct subfamily of 5-hydroxytryptamine receptors differentially expressed in rat brain. Proc Natl Acad Sci U S A 90(8):3452-3456.
68. Forbes IT, Dabbs S, Duckworth DM et al (1998) (R)-3, N -dimethyl158 N -[1-methyl-3-(4-methylpiperidinyl- 1-yl) propyl]benzensulfonamide: the fi rst selective 5-HT7 antagonist. J Med Chem 41:655-657.
69. Fukunaga K, Shioda N (2012) Novel dopamine D2 receptor signaling through proteins interacting with the third cytoplasmic loop. Mol Neurobiol 45(1):144-152.
70. Funahashi M, Stewart M (1998) Properties of gamma-frequency oscillations initiated by propagating population bursts in retrohippocampal regions of rat brain slices. J Physiol 510(Pt 1):191-208.
71. Gether U, Asmar F, Meinild AK, Rasmussen SG (2002) Structural basis for activation of G-proteincoupled receptors. Pharmacol Toxicol 91(6):304-312.
72. Gotti C, Clementi F (2004) Neuronal nicotinic receptors: from structure to pathology. Prog Neurobiol 74:363-396.
73. Gotti C, Clementi F, Fornari A et al (2009) Structural and functional diversity of native brain neuronal nicotinic receptors. Biochem Pharmacol 78(7):703-711.
74. Hague C, Chen Z, Uberti M, Minneman KP (2003) Alpha(1)-adrenergic receptor subtypes: nonidentical triplets with different dancing partners ? Life Sci 74(4):411-418.
75. Haydar SN, Dunlop J (2010) Neuronal nicotinic acetylcholine receptors - targets for the development of drugs to treat cognitive impairment associated with schizophrenia and Alzheimer's disease. Curr Top Med Chem 10(2):144-152.
76. Hirano K, Piers TM, Searle KL, Miller ND, Rutter AR, Chapman PF (2009) Procognitive 5-HT6 antagonists in the rat forced swimming test: potential therapeutic utility in mood disorders associated with Alzheimer's disease. Life Sci 84(15-16):558-562.
77. Hostetler CM, Harkey SL, Krzywosinski TB, Aragona BJ, Bales KL (2011) Neonatal exposure to the D1 agonist SKF38393 inhibits pair bonding in the adult prairie vole. Behav Pharmacol 22(7):703-710.
78. Hoyer D, Clarke DE, Fozard JR et al (1994) International union of pharmacology: classifi cation of receptors for 5 hydroxytryptamine (serotonin). Pharmacol Rev 46:157-205.
79. Huang Y, Qiu AW, Peng YP, Liu Y, Huang HW, Qiu YH (2010) Roles of dopamine receptor subtypes in mediating modulation of T lymphocyte function. Neuro Endocrinol Lett 31(6):782-791.
80. Ishikawa M, Hashimoto K (2011) Alpha7 nicotinic acetylcholine receptor as a potential therapeutic target for schizophrenia. Curr Pharmacol Des 17(2):121-129.
81. Joyce JN, Meador-Woodruff JH (1997) Linking the family of D2 receptors to neuronal circuits in human brain: insights into schizophrenia. Neuropsychopharmacology 16(6):375-384.
82. Kabashima N, Shibuya I, Ibrahim N, Ueta Y, Yamashita H (1997) Inhibition of spontaneous EPSCs and IPSCs by presynaptic GABA B receptors on rat supraoptic magnocellular neurons. J Physiol 504(Pt 1):113-126.
83. Kawamata J, Shimohama SS (2011) Stimulating nicotinic receptors trigger multiple pathways attenuating cytotoxicity in models of Alzheimer's and Parkinson's diseases. J Alzheimers Dis 24(Suppl 2):95-109.
84. Kem WR (2000) The brain alpha7 nicotinic receptor may be an important therapeutic target for the treatment of Alzheimer's disease: studies with DMXBA (GTS-21). Behav Brain Res 113(1-2): 169-181.
85. King MV, Marsden CA, Fone KC (2008) A role for the 5-HT(1A), 5-HT4 and 5-HT6 receptors in learning and memory. Trends Pharmacol Sci 29(9):482-492.
86. Kogan HA, Marsden CA, Fone KC (2002) DR4004, a putative 5-HT(7) receptor antagonist, also has functional activity at the dopamine D2 receptor. Eur J Pharmacol 449(1-2):105-111.
87. Kvernmo T, Houben J, Sylte I (2008) Receptor-binding and pharmacokinetic properties of dopaminergic agonists. Curr Top Med Chem 8(12):1049-1067.
88. Labrakakis C, Tong CK, Weissman T, Torsney C, MacDermott AB (2003) Localization and function of ATP and GABA A receptors expressed by nociceptors and other postnatal sensory neurons in rat. J Physiol 549(Pt 1):131-142.
89. Langmead CJ, Watson J, Reavill C (2008) Muscarinic acetylcholine receptors as CNS drug targets. Pharmacol Ther 117(2):232-243.
90. Lovell PJ, Bromidge SM, Dabbs S et al (2000) A novel, potent, and selective 5-HT7 antagonist: (R)-3-(2-(2-(4-methylpiperin-1-yl)-ethyl)pyrrolidine-1-sulfonyl)phenol (SB-269970). J Med Chem 43:342-345.
91. Lucas G, Rymar VV, Du J et al (2007) Serotonin(4) (5-HT(4)) receptor agonists are putative antidepressants with a rapid onset of action. Neuron 55(5):712-725.
92. MacDonald E, Scheinin M (1995) Distribution and pharmacology of alpha 2-adrenoceptors in the central nervous system. J Physiol Pharmacol 46(3):241-258.
93. Mahe C, Loetscher E, Feuerbach D, Muller W, Seiler MP, Schoeffter P (2004) Differential inverse agonist effi cacies of SB-258719, SB-258741 and SB-269970 at human recombinant serotonin 5-HT7 receptors. Eur J Pharmacol 495(2-3):97-102.
94. Marien MR, Colpaert FC, Rosenquist AC (2004) Noradrenergic mechanisms in neurodegenerative diseases: a theory. Brain Res Rev 45:38-78.
95. Martelle JL, Nader MA (2008) A review of the discovery, pharmacological characterization, and behavioral effects of the dopamine D2-like receptor antagonist eticlopride. CNS Neurosci Ther 14(3):248-262.
96. Martin P, Lemonier F (1994) Interet des recepteurs serotoninergiques de type 2: 5HT 2a et 5HT 2c, dans les troubles depressifs: action de la medifoxamine. L'encéphale 20:427-435.
97. Meitzen J, Luoma JI, Stern CM, Mermelstein PG (2011) Alpha1-adrenergic receptors activate two distinct signaling pathways in striatal neurons. J Neurochem 116(6):984-995.
98. Meneses A (1999) 5-HT system and cognition. Neurosci Biobehav Rev 23(8):1111-1125.
99. Mesulam MM (1998) From sensation to cognition. Brain 121(6):1013-1052.
100. Meunier JM, Shvaloff A (1995) Neurotransmetteurs: bases neurobiologiques et pharmacologiques. Editions Masson, Paris.
101. Millar NS, Gotti C (2009) Diversity of vertebrate nicotinic acetylcholine receptors. Neuropharmacology 56(1):237-246.
102. Mirza NR, Larsen JS, Mathiasen C et al (2008) NS11394 [3'-[5-(1-hydroxy-1-methyl-ethyl)- benzoimidazol- 1-yl]-biphenyl-2-carbonitrile], a unique subtype-selective GABA A receptor positive allosteric modulator: in vitro actions, pharmacokinetic properties and in vivo anxiolytic effi cacy. J Pharmacol Exp Ther 327(3):954-968.
103. Mlinar B, Mascalchi S, Mannaioni G, Morini R, Corradetti R (2006) 5-HT4 receptor activation induces long-lasting EPSP-spike potentiation in CA1 pyramidal neurons. Eur J Neurosci 24(3):719-731.
104. Mohler EG, Shacham S, Noiman S et al (2007) VRX-03011, a novel 5-HT4 agonist, enhances memory and hippocampal acetylcholine efflux. Neuropharmacology 53(4): 563-573.
105. Momiyama T (2010) Developmental increase in D1-like dopamine receptor-mediated inhibition of glutamatergic transmission through P/Q-type channel regulation in the basal forebrain of rats. Eur J Neurosci 32(4):579-590.
106. Nasser Y, Ho W, Sharkey KA (2006) Distribution of adrenergic receptors in the enteric nervous system of the guinea pig, mouse, and rat. J Comp Neurol 495(5):529-553.
107. Nelson DL (2004) 5-HT5 receptors. Current drug targets. CNS Neurol Disord 3(1):53-58.
108. O'Keefe GC, Barker RA, Caldwell MA (2009) Dopaminergic modulation of neurogenesis in the subventricular zone of the adult brain. Cell Cycle 8(18):2888-2894.
109. Palma E, Conti L, Roseti C, Limatola C (2012) Novel approaches to study the involvement of a7-nAChR in human diseases. Curr Drug Targets 13:579-586.
110. Parga J, Rodriguez-Pallares J, Munoz A, Guerra MJ, Labandeira-Garcia JL (2007) Serotonin decreases generation of dopaminergic neurons from mesencephalic precursors via serotonin type 7 and type 4 receptors. Dev Neurobiol 67(1):10-22.
111. Parri HR, Hernandez CM, Dineley KT (2011) Research update: alpha7 nicotinic acetylcholine receptor mechanisms in Alzheimer's disease. Biochem Pharmacol 82(8):931-942.
112. Parsons CG (2001) NMDA receptors as targets for drug action in neuropathic pain. Eur J Pharmacol 429(1-3):71-78.
113. Patenaude C, Chapman CA, Bertrand S, Congar P, Lacaille JC (2003) GABA B receptor- and metabotropic glutamate receptor-dependent cooperative long-term potentiation of rat hippocampal GABA A synaptic transmission. J Physiol 553(Pt 1):155-167.
114. Quik M, Huang LZ, Parameswaran N, Bordia T, Campos C, Perez XA (2009) Multiple roles for nicotine in Parkinson's disease. Biochem Pharmacol 78(7):677-685.
115. Ramos BP, Arnsten AF (2007) Adrenergic pharmacology and cognition: focus on the prefrontal cortex. Pharmacol Ther 113(3):523-536.
116. Reever CM, Ferrari-DiLeo G, Flynn DD (1997) The M5 (m5) receptor subtype: fact or fi ction ? Life Sci 60(13-14):1105-1112.
117. Reis GM, Duarte ID (2006) Baclofen, an agonist at peripheral GABAB receptors, induces antinociception via activation of TEA-sensitive potassium channels. Br J Pharmacol 149(6): 733-739.
118. Restivo L, Roman F, Dumuis A, Bockaert J, Marchetti E, Ammassari-Teule M (2008) The promnesic effect of G-protein-coupled 5-HT4 receptors activation is mediated by a potentiation of learning induced spine growth in the mouse hippocampus. Neuropsychopharmacology 33(10):2427-2434.
119. Riccioni T (2011) 5-HT6 receptor characterization. Int Rev Neurobiol 94:67-88.
120. Saunders C, Limbird LE (1999) Localization and traffi cking of alpha2-adrenergic receptor subtypes in cells and tissues. Pharmacol Ther 84(2):193-205.
121. Schaffhauser H, Mathiasen JR, Dicamillo A et al (2009) Dimebolin is a 5-HT6 antagonist with acute cognition enhancing activities. Biochem Pharmacol 78(8):1035-1042.
122. Schechter LE, Lin Q, Smith DL et al (2008) Neuropharmacological profi le of novel and selective 5-HT6 receptor agonists: WAY-181187 and WAY-208466. Neuropsychopharmacology 33(6): 1323-1335.
123. Schliebs R, Arendt T (2011) The cholinergic system in aging and neuronal degeneration. Behav Brain Res 221(2):555-563.
124. Schmitt KC, Reith ME (2010) Regulation of the dopamine transporter: aspects relevant to psychostimulant drugs of abuse. Ann NY Acad Sci 1187:316-340.
125. Shen KZ, Johnson SW (1997) Presynaptic GABAB and adenosine A1 receptors regulate synaptic transmission to rat substantia nigra reticulata neurones. J Physiol 505(1):153-163.
126. Slassi A, Methvin I, Xin T (2004) Recent progress in 5-HT7 receptors: potential treatment of central and peripheral nervous system diseases. Expert Opin Ther Pat 14:1009-1027.
127. Sotoyama H, Zheng Y, Iwakura Y et al (2011) Pallidal hyperdopaminergic innervation underlying D2 receptor-dependent behavioral defi cits in the schizophrenia animal model established by EGF. PLoS One 6(10):e25831.
128. Sulzer D (2011) How addictive drugs disrupt presynaptic dopamine neurotransmission. Neuron 69(4):628-649.
129. Sun W (2011) Dopamine neurons in the ventral tegmental area: drug-induced synaptic plasticity and its role in relapse to drug-seeking behavior. Curr Drug Abuse Rev 4(4):270-285.
130. Sun L, Chiu D, Kowal D et al (2004) Characterization of two novel N -methyl- d -aspartate antagonists: EAA-090 (2-[8,9-dioxo-2,6-diazabicyclo [5.2.0]non-1(7)-en2-yl]ethylphosphonic acid) and EAB-318 (R-alpha-amino-5-chloro-1-(phosphonomethyl)-1 H -benzimidazole-2-propanoic acid hydrochloride). J Pharmacol Exp Ther 310(2):563-750.
131. Thomas DR (2006) 5-ht5A receptors as a therapeutic target. Pharmacol Ther 111(3):707-714.
132. Thomas DR, Hagan JJ (2004) 5-HT7 receptors. Current drug targets. CNS Neurol Disord 3:81-90.
133. Thomas DR, Melotto S, Massagrande M et al (2003) SB-656104-A, a novel selective 5-HT7 receptor antagonist, modulates REM sleep in rats. Br J Pharmacol 139:705-714.
134. Thomsen WJ, Grottick AJ, Menzaghi F et al (2008) Lorcaserin, a novel selective human 5- hydroxytryptamine2C agonist: in vitro and in vivo pharmacological characterization. J Pharmacol Exp Ther 325(2):577-587.
135. Tuesta LM, Fowler CD, Kenny PJ (2011) Recent advances in understanding nicotinic receptor signaling mechanisms that regulate drug self-administration behavior. Biochem Pharmacol 82(8):984-995.
136. Van Veldhuizen MJA, Feenstra MGP, Heinsbroek RPW, Boer GJ (1993) In vivo microdialysis of noradrenaline overfl ow: effects of alpha-adrenoceptor agonists and antagonists measured by cumulative concentration response curves. Br J Pharmacol 109:655-660.
137. Wallace TL, Porter RH (2011) Targeting the nicotinic alpha7 acetylcholine receptor to enhance cognition in disease. Biochem Pharmacol 82(8):891-903.
138. Weiss B, Alt A, Ogden AM et al (2006) Pharmacological characterization of the competitive GLUK5 receptor antagonist decahydroisoquinoline LY466195 in vitro and in vivo. J Pharmacol Exp Ther 318(2):772-781.
139. Wilson JM, Sanyal S, Van Tol HH (1998) Dopamine D2 and D4 receptor ligands: relation to antipsychotic action. Eur J Pharmacol 351(3):273-286.
140. Xie A, Song X, Ripps H, Qian H (2008) Cyclothiazide: a subunit-specifi c inhibitor of GABA C receptors. J Physiol 586(Pt 11):2743-2752.
141. Yang L, Omori K, Omori K, Otani H, Suzukawa J, Inagaki C (2003) GABAC receptor agonist suppressed ammonia-induced apoptosis in cultured rat hippocampal neurons by restoring phosphorylated BAD level. J Neurochem 87(3):791-800.
142. Yang JC, Fan XL, Song XA, Li Q (2008) The role of different glutamate receptors in the mediation of glutamate-evoked excitation of red nucleus neurons after simulated microgravity in rat. Neurosci Lett 448(3):255-259.
143. Zigmond MJ, Stricker EM (1984) Parkinson's disease: studies with an animal model. Life Sci 35(1):5-18.
144. Albe-Fessard D, Stutinsky F, Libouan S (1966) Atlas stéréotaxique du diencéphale du rat blanc. éditions du Centre National de la Recherche Scientifi que, Paris.
145. Altman J, Bayer SA (1994) Atlas of prenatal rat brain development. CRC Press, Inc., Boca Raton.
146. Cooley RK (1990) Stereotaxic surgery in the rat: a photographic series. A.J. Kirby Co, London.
147. Dashwood MR, Loesch A (2010) Endothelin-1 as a neuropeptide: neurotransmitter or vascular effects? J Cell Commun Signal 4(1):51-62.
148. De La Porte C (1993) Technical possibilities and limitations of stereotaxy. Acta Neurochir (Wien) 124(1):3-6.
149. Franklin KBJ, Paxinos G (2008) The mouse brain in stereotaxic coordinates, 3rd edn. Academic/ Elsevier, Oxford.
150. König JFR, Klippel RA (1963) The rat brain: a stereotaxic atlas of the forebrain and the lower parts of the brain stem. Williams and Wilkins, Baltimore.
151. Lehmann A, Gautier M, Ghilini G, Henry J, Langlois R, Laplante S (1974) Atlas stéréotaxique du cerveau de la souris. éditions du Centre de la Recherche Scientifi que, Paris.
152. Montemurro DG, Dukelow RH (1971) A stereotaxic atlas of the diencephalon and related structures of the mouse. Mount Kisco/Future, New York.
153. Paxinos G, Franklin KBJ (2001) The mouse brain in stereotaxic coordinates, 2nd edn. Elsevier, New York.
154. Paxinos G, Franklin KBJ (2003) The mouse brain in stereotaxic coordinates: compact, Compact 2nd edn. Elsevier, New York.
155. Paxinos G, Franklin KBJ (2012) The mouse brain in stereotaxic coordinates, Compact 4th edn. Elsevier, New York.
156. Paxinos G, Watson C (1998) The rat brain in stereotaxic coordinates, Compact 4th edn. Academic, New York.
157. Paxinos G, Watson C (2004) The rat brain in stereotaxic coordinates, 5th edn. Academic, San Diego.
158. Paxinos G, Watson C (2007) The rat brain in stereotaxic coordinates, 6th edn. Academic, San Diego.
159. Paxinos G, Watson C (2013) The rat brain in stereotaxic coordinates, 7th edn. Academic, San Diego. ISBN 9780123919496.
160. Pellegrino LJ, Cushman AJ (1967) A stereotaxic atlas of the rat brain. Appleton-Century-Crofts, New York.
161. Schambra UB, Lauder JM, Silver J (1991) Atlas of the prenatal mouse brain. Academic, New York.
162. Sidman RL, Angevine JB Jr, Taber PE (1971) Atlas of the mouse brain and spinal cord. Harvard University Press, Cambridge. Mass.
163. Swanson L (2003) Brain maps: structure of the rat brain, 3rd edn. Elsevier, New York.
164. Bekker A, Sturaitis MK (2005) Dexmedetomidine for neurological surgery. Neurosurgery 57(1 Suppl):1-10.
165. Blasiak T, Czubak W, Ignaciak A, Lewandowski MH (2010) A new approach to detection of the bregma point on the rat skull. J Neurosci Methods 185(2):199-203.
166. Chery R, Gurden H, Martin C (2012) Anesthetic regimes differentially modulate the spontaneous and odor-induced temporal dynamics in the mouse olfactory bulb. (Submitted).
167. Drummond J (2000) Monitoring depth of anesthesia, with emphasis on the application of the bispectral index and the middle latency auditory evoked response to the prevention of recall. Anesthesiology 93:876-882.
168. Edlich RF, Long WB (2008) Covidien surgical knot tying manual. Covidien, Norwalk, p 95, www. covidien.com.
169. Ethicon, Inc (1986) Knot tying manual. Ethicon, Somerville, p 40, http://www.sutureonline.com/ suture-knot-tying-manual.
170. Farber NE, Harkin CP, Niedfeldt J, Hudetz AG, Kampine JP, Schmeling WT (1997) Regionspecifi c and agent-specifi c dilation of intracerebral microvessels by volatile anesthetics in rat brain slices. Anesthesiology 87(5):1191-1198.
171. Ferrante FM, Paggioli J, Cherukuri S, Arthur GR (1996) The analgesic response to intravenous lidocaine in the treatment of neuropathic pain. Anesth Analg 82:91-97.
172. Fornari RV, Wichmann R, Atsak P et al (2012) Rodent stereotaxic surgery and animal welfare outcome improvements for behavioral neuroscience. J Vis Exp (59). doi: 10.3791/3528.
173. Harrison NL (2003) Knockin' on the door of general anesthetic mechanisms: but will US researchers be shut out ? Anesth Analg 97:616-618.
174. Hemming HC Jr (2009) Sodium channels and the synaptic mechanisms of inhaled anaesthetics. Br J Anaesth 103(1):61-69.
175. Jensen EW, Litvan H, Struys M, Vazquez M (2004) Pitfalls and challenges when assessing the depth of hypnosis during general anesthesia by clinical signs and electronic indices. Acta Anaesthesiol Scand 48:1267-1269.
176. Joris J (2008) La lidocaïne par voie intraveineuse. Revue Médicale de Lièges 63:2-9.
177. Jurd R, Arras M, Lambert S et al (2003) General anesthetic actions in vivo strongly attenuated by a point mutation in the GABA(A) receptor beta3 subunit. Off Publ Fed Am Soc Exp Biol 17:250-252.
178. Koppert W, Ostermeier N, Sittl R, Weidner C, Schmelz M (2000) Low-dose lidocaine reduces secondary hyperalgesia by a central mode of action. Pain 85:217-224.
179. Kuno M, Matsuura S (1982) Sites and mechanisms of action of lidocaine upon the isolated spinal cord of the frog. Brain Res 249:87-93.
180. Li X, Wu J, Zheng J, Li Y, Yang T, Hu G, Dai J, Yang Q, Dai L, Jiang Y (2013) Altered miRNA expression profi les and miR-1a associated with urethane-induced pulmonary carcinogenesis. Toxicol Sci 135(1):63-71.
181. Mason RJ, Kalina M, Nielsen LD, Malkinson AM, Shannon JM (2000) Surfactant protein C expression in urethane-induced murine pulmonary tumors. Am J Pathol 156:175-182.
182. Messier C, Emond S, Ethier K (1999) New techniques in stereotaxic surgery and anesthesia in the mouse. Pharmacol Biochem Behav 63(2):313-318.
183. Nagy I, Woolf CJ (1996) Lignocaine selectively reduces C fi bre-evoked neuronal activity in rat spinal cord in vitro by decreasing N -methyl- d -aspartate and neurokinin receptor mediated postsynaptic depolarizations; implications for the development of novel centrally acting analgesics. Pain 64:59-70.
184. Nelson LE, Guo TZ, Lu J, Saper CB, Franks NP, Maze M (2002) The sedative component of anesthesia is mediated by GABA(A) receptors in an endogenous sleep pathway. Nat Neurosci 5:979-984.
185. Paxinos G, Watson C (2004) The rat brain in stereotaxic coordinates, 5th edn. Academic, San Diego.
186. Richardson CA, Flecknell PA (2005) Anaesthesia and post-operative analgesia following experimental surgery in laboratory rodents: are we making progress ? Altern Lab Anim 33(2):119-127.
187. Shavit Y, Fish G, Wolf G et al (2005) The effects of perioperative pain management techniques on food consumption and body weight after laparotomy in rats. Anesth Analg 101:1112-1116.
188. Smith DJ, Perrotti JM, Mansell AL, Monroe PJ (1985) Ketamine analgesia is not related to an opiate action in the periaqueductal gray region of the rat brain. Pain 21(3):253-265.
189. Sonner JM, Antognini JF, Dutton RC et al (2003) Inhaled anesthetics and immobility: mechanisms, mysteries and MAC. Anesth Analg 97:718-740.
190. Stokes EL, Flecknell PA, Richardson CA (2009) Reported analgesic and anaesthetic administration to rodents undergoing experimental surgical procedures. Lab Anim 43(2):149-154.
191. Tanelian DL, MacIver MB (1991) Analgesic concentrations of lidocaine suppress tonic A-delta and C fi ber discharges produced by acute injury. Anesthesiology 74:934-936.
192. Vizcaychipi MP, Lloyd DG, Wan Y, Palazzo MG, Maze M, Daqing M (2011) Xenon pretreatment may prevent early memory decline after isofl urane anesthesia. PLoS One 6(11):1-7.
193. Waite A, Gilliver SC, Masterson GR, Hardman MJ, Ashcroft GS (2010) Clinically relevant doses of lidocaine and bupivacaine do not impair cutaneous wound healing in mice. Br J Anaesth 104(6):768-773.
194. Wallace MS, Dyck JB, Rossi SS, Yaksh TL (1996) Computer-controlled lidocaine infusion for the evaluation of neuropathic pain after peripheral nerve injury. Pain 66:69-77.
195. Berridge KC, Whishaw IQ (1992) Cortex, striatum and cerebellum: control of serial order in a grooming sequence. Exp Brain Res 90(2):275-290.
196. Blasiak T, Czubak W, Ignaciak A, Lewandowski MH (2010) A new approach to detection of the bregma point on the rat skull. J Neurosci Methods 185(2):199-203.
197. Blum D, Torch S, Lambeng N et al (2001) Molecular pathways involved in the neurotoxicity of 6-OHDA, dopamine and MPTP: contribution to the apoptotic theory in Parkinson's disease. Prog Neurobiol 65(2):135-172.
198. Buchen L (2010) Illuminating the brain. Nature 465:26-28.
199. Centonze D, Calabresi P, Giacomini P, Bernardi G (1999) Neurophysiology of Parkinson's disease: from basic research to clinical correlates. Clin Neurophysiol 110(12):2006-2013.
200. Chen Z, Ong BH, Kambouris NG, Marban E, Tomaselli GF, Balser JR (2000) Lidocaine induces a slow inactivated state in rat skeletal muscle sodium channels. J Physiol 524:37-49.
201. Dudley MW, Howard BD, Cho AK (1990) The interaction of the beta-haloethyl benzylamines, xylamine, and DSP-4 with catecholaminergic neurons. Annu Rev Pharmacol Toxicol 30:387-403.
202. Duncan RJS, Sourkes TL, Dubrovsky BO, Quik M (1975) Activity of aldehyde dehydrogenase, aldehyde reductase and acetylcholine esterase in striatum of rats bearing electrolytic lesions of the medial forebrain bundle. J Neurochem 24(1):143-147.
203. Ferry B, McGaugh JL (2008) Involvement of the basolateral amygdala a 2 -adrenoceptors in memory modulation of inhibitory avoidance in the rat. Learn Mem 15(4):238-243.
204. Ferry B, Sandner G, Di Scala G (1995) Neuroanatomical and functional specifi city of basolateral amygdaloid nucleus in taste potentiated odor aversion. Neurobiol Learn Mem 64:169-180.
205. Ferry B, Wirth S, Di Scala G (1999) Functional interaction between entorhinal cortex and basolateral amygdala during trace conditioning of odor aversion in the rat. Behav Neurosci 113(1):118-125.
206. Fritschy JM, Grzanna R (1991) Selective effects of DSP-4 on locus coeruleus axons: are there pharmacologically different types of noradrenergic axons in the central nervous system? Prog Brain Res 88:257-268.
207. Gervasoni D, Darracq L, Fort P, Souliere S, Chouvet G, Luppi PH (1998) Electrophysiological evidence that noradrenergic neurons of the locus coeruleus are tonically inhibited by GABA during sleep. Eur J Neurosci 10:964-970.
208. Gervasoni D, Peyron C, Rampon C et al (2000) Role and origin of the GABAergic innervations of dorsal raphe serotonergic neurones. J Neurosci 20:4217-4225.
209. Glinka Y, Gassen M, Youdim MB (1997) Mechanism of 6-hydroxydopamine neurotoxicity. J Neural Transm 50:55-66.
210. Goldstein LB (1993) Beam-walking in rats: the measurement of motor recovery after injury to the cerebral cortex. Neurosci Protoc 10(3):1-13.
211. Jarrard LE (2002) Use of excitotoxins to lesion the hippocampus: update. Hippocampus 12(3):405-414.
212. Jonsson G (1980) Chemical neurotoxins as denervation tools in neurobiology. Annu Rev Neurosci 3:169-187.
213. King BM (1991) Comparison of electrolytic and radio-frequency and lesion methods. Methods Neurosci 7:90-97.
214. Kostrzewa RM (1995) Dopamine receptor supersensitivity. Neurosci Biobehav Rev 19(1):1-17.
215. Kostrzewa RM (2009) Evolution of neurotoxins: from research modalities to clinical realities. Curr Protoc Neurosci 1: Unit 1.18.
216. Kostrzewa RM, Brus R (1998) Destruction of catecholamine-containing neurons by 6- hydroxydopa, an endogenous amine oxidase cofactor. Amino Acids 14(1-3):175-179.
217. Li Y, Peris J, Zhong L, Derendorf H (2006) Microdialysis as a tool in local pharmacodynamics. AAPS J 8(2):222-235.
218. Livingston-Thomas JM, Hume AW, Doucette TA, Tasker RA (2013) A novel approach to induction and rehabilitation of defi cits in forelimb function in a rat model of ischemic stroke. Acta Pharmacol Sin 34(1):104-112.
219. McGaughy J, Everitt BJ, Robbins TW, Sarter M (2000) The role of cortical cholinergic afferent projections in cognition: impact of new selective immunotoxins. Behav Brain Res 115(2):251-263.
220. Messier C, Emond S, Ethier K (1998) New techniques in stereotaxic surgery and anesthesia in the mouse. Pharmacol Biochem Behav 63(2):313-318.
221. Milner TA, Amaral DG (1984) Evidence for a ventral septal projection to the hippocampal formation of the rat. Exp Brain Res 55(3):579-585.
222. Rotman A, Creveling CR (1976) A rationale for the design of cell-specifi c toxic agents: the mechanism of action of 6-hydroxydopamine. FEBS Lett 72(2):227-230.
223. Schliebs R, Rossner S, Bigl V (1996) Immunolesion by 192IgG-saporin of rat basal forebrain cholinergic system: a useful tool to produce cortical cholinergic dysfunction. Prog Brain Res 109:253-264.
224. Schwarting RK, Huston JP (1996) The unilateral 6-hydroxydopamine lesion model in behavioral brain research. Analysis of functional defi cits, recovery and treatments. Prog Neurobiol 50(2-3):275-331.
225. Schwarting RK, Huston JP (1997) Behavioral and neurochemical dynamics of neurotoxic mesostriatal dopamine lesions. Neurotoxicology 18(3):689-708.
226. Urbain N, Rentero N, Gervasoni D, Renaud B, Chouvet G (2002) The switch of subthalamic neurons from an irregular to a bursting pattern does not solely depend on their GABAergic inputs in the anesthetic-free rat. J Neurosci 22:8665-8675.
227. Urbain N, Creamer K, Debonnel G (2006) Electrophysiological diversity of the dorsal raphe cells across the sleep-wake cycle of the rat. J Physiol 573:679-695.
228. Vargo JM, Marshall JF (1996) Unilateral frontal cortex ablation producing neglect causes timedependent changes in striatal glutamate receptors. Behav Brain Res 77(1-2):189-199.
229. Wiley RG (1992) Neural lesioning with ribosome-inactivating proteins: suicide transport and immunolesioning. Trends Neurosci 15(8):285-290.
230. Wiley RG (1997) Findings about the cholinergic basal forebrain using immunotoxin to the nerve growth factor receptor. Ann NY Acad Sci 835:20-29.
231. Wiley RG (2001) Targeting toxins to neural antigens and receptors. Methods Mol Biol 166:267-276.
232. Directive 2010/63/EU du Parlement Européen et du Conseil (22 septembre 2010) sur la protection des animaux en expérimentation scientifi que. Journal offi ciel de l'Union Européenne (Offi cial Journal of the European Union), Strasbourg.
233. Ferry B, Sandner G, Di Scala G (1995) Neuroanatomical and functional specifi city of basolateral amygdaloid nucleus in taste potentiated odor aversion. Neurobiol Learn Mem 64:169-180.
234. Ferry B, Oberling P, Jarrard LE, Di Scala G (1996) Facilitation of conditioned odor aversion learning by entorhinal cortex lesions in the rat. Behav Neurosci 110(3):443-450.
235. Ferry B, Wirth S, Di Scala G (1999) Functional interaction between entorhinal cortex and basolateral amygdala during trace conditioning of odor aversion in the rat. Behav Neurosci 113(1):118-125.
236. Ferry B, Ferreira G, Traissard N, Majchrzak M (2006) Selective involvement of the lateral entorhinal cortex in the control of the olfactory memory trace during conditioned odor aversion in the rat. Behav Neurosci 120(5):1180-1186.
237. Ferry B, McGaugh JL (2008) Involvement of the basolateral amygdala a 2 -adrenoceptors in memory modulation of inhibitory avoidance in the rat. Learn Mem 15(4):238-243.
238. Franklin KBJ, Paxinos G (2008) The mouse brain in stereotaxic coordinates, 3rd edn. Oxford Academic Press, Oxford.
239. Gervasoni D, Darracq L, Fort P, Souliere S, Chouvet G, Luppi PH (1998) Electrophysiological evidence that noradrenergic neurons of the locus coeruleus are tonically inhibited by GABA during sleep. Eur J Neurosci 10:964-970.
240. Gervasoni D, Peyron C, Rampon C et al (2000) Role and origin of the GABAergic innervations of dorsal raphe serotonergic neurones. J Neurosci 20:4217-4225.
241. Paxinos G, Watson C (2004) The rat brain in stereotaxic coordinates, 5th edn. Academic, San Diego.
242. Piper M, Treuting S, Dintzis M (2011) Comparative anatomy and histology: a mouse and human atlas. Elsevier Academic Press, San Diego: USA.
243. Ross MH, Pawlina W (2006) Histology: a text and atlas with correlated cells and microbiology, 5th edn. Lippincott Williams and Wilkins, Philadelphia, pp 318-352.
244. Stevens A, Lowe J, Young B (2002) Wheater's basic histopathology: a text and color atlas, 4th edn. Churchill Livingstone, Edinburgh.
245. Young B, Heath JW (2000) Wheater's Functional Histology, 4th edn. Churchill Livingstone, Edinburgh.
246. Young B, Lowe J, Stevens A, Heath, JW (2006) Wheather's functional histology: a text and color atlas, 5th edn. Churchill Livingstone, Edinburgh.